Anderson Cancer Center, Houston, Texas, USA.
Introduction
Antimicrobial resistance (AMR) is an emerging global health priority (1). Carbapenem resistant Enterobacteriaceae (CRE) are among the most serious AMR threats (2, 3) . CRE can develop due to the presence of a carbapenem hydrolyzing enzyme (i.e., a carbapenemase) as well as through decreased intracellular concentrations of carbapenems resulting from changes in outer membrane permeability or drug efflux (4-6). Although most CRE research has focused on carbapenemases such as Klebsiella pneumoniae carbapenemase (KPC) (7), a recent systematic survey of CRE in the United States identified a carbapenemase in less than 50% of CRE isolates suggesting that non-carbapenemase based mechanisms are major contributors to CRE (8).
Escherichia coli and K. pneumoniae account for the majority of non-carbapenemase producing CRE (non-CP-CRE) (9-12). Clinical non-CP-CRE isolates for both species generally have extended spectrum β -lactamases (ESBL) or AmpC-like enzymes as well as mutations that alter porin function (13) (14) (15) (16) (17) . In vitro models of non-CP-CRE have shown that the presence of an ESBL or AmpC enzyme is critical to the subsequent development of carbapenem resistance as strains lacking such enzymes do not develop carbapenem resistance during serial passage (12, 18) . However, it is becoming increasingly clear that both the presence as well as the copy number of β -lactamases have important impacts on β -lactam susceptibility (19). For example, increasing the expression of the non-carbapenemase β -lactamases TEM-1, OXA-1, and CTX-M-15 in an E. coli porin deficient strain increased carbapenem minimum inhibitory concentrations (MIC) (18), while serial passaging of an ESBL or AmpC-producing isolate in the presence of a carbapenem can result in amplification of plasmid-borne β -lactamase genes (20) . It is thought that tazobactam resistance (23), indicating that the effects of β -lactamase gene dosage are not limited to carbapenems.
The paucity of serially collected, clinical Enterobacteriaceae with an ESBL (ESBL-E) that are initially carbapenem sensitive, which develop a subsequent carbapenem resistant phenotype indicates that it is not clear whether the clinical development of carbapenem resistance in an ESBL-E strain mirrors that of laboratory conditions (15, (24) (25) (26) (27) . Several studies of serial, clinical E. coli strains expressing a bla CMY variant that produces an AmpC β -lactamase have shown that clinical non-CP-CRE isolates contain inactivated porins relative to their carbapenem-susceptible precursors; however, these studies did not examine bla CMY gene amplification (24) (25) (26) . Furthermore, the vast majority of clinical non-CP-CRE harbor CTX-M β -lactamases (14, 16, 28, 29) , and much less is known about how carbapenem resistance develops in such isolates.
Recently, whole genome sequencing (WGS) of a pair of E. coli isolates containing the ESBL gene, bla , identified that a single amino acid change in the OmpR protein, which regulates production of porins known as outer membrane protein C (OmpC) and OmpF, resulted in development of carbapenem resistance; however, no information was provided regarding bla CTX-M copy numbers in the genome (15).
We recently identified that the vast majority of Enterobacteriaceae isolates resistant to 3 rd generation cephalosporins at our institution contain bla CTX-M (30). Moreover, short-read Illumina WGS revealed high level read mapping to β -lactamase encoding genes in numerous isolates suggestive of ESBL gene 
18, 20).
For patient 10, we observed that isolate C (ESBL-E phenotype) contained identical wild-type ompC and ompF sequences as did the parent isolate, isolate A (ESBL-E phenotype), in contrast to isolate B (non-CP-CRE phenotype) in which ompC and ompF were interrupted by a 16 bp and an 11 bp deletion, respectively. For patient 11, ompF was mutated in both the initial isolate A (ESBL-E phenotype) and subsequent isolate B (non-CP-CRE phenotype) whereas ompC was only mutated (2 bp deletion) in the subsequent isolate B, non-CP-CRE strain. The location and extent of the deletions are labeled. For patient 11, both isolate A and B had deletions in ompF relative to wild-type, such that the ompF sequence from the E. coli reference strain MG1655 is shown for reference purposes. The corresponding phenotype is abbreviated as follows: ESBL-E = extended spectrum β -lactamase producing Enterobacteriaceae, non-CP-CRE = non-carbapenemase producing carbapenem-resistant Enterobacteriaceae.
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Fig. 3. Translocatable unit MB1860TU characterization of patient 4 isolates with noted increase of WGS per-base coverage amongst serial isolates. (A) Map of MB1860TU noted in black brackets
identified from the initial ESBL isolate of patient 4 (MB1860). ORFs and MGEs are indicated by colored arrows and boxes with mobile genetic elements (white), AMR determinants (maroon), and other genes (gray) labelled respectively. Delta (Δ) next to annotated genetic region indicates a truncation or disruption. Black arrows beneath IS26 elements indicate directionality of IS26 transposases. bla (blue) carried by MB1860TU is upstream of bla (green) . (B) Increasing coverage depth of MB1860TU for patient 4 serial isolates MB1860 (1X), MB2374 (11X), MB2463 (18X), and MB2573 (27X) respectively. MB1860TU mean coverage depth was normalized to the mean coverage depth for ST131 housekeeping genes.
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As previously noted, nearly half of the strains in our cohort, including all serial non-CP-CRE isolates, had increased read mapping depth for β -lactamase encoding genes (Table 1) . Nevertheless, we could not use the short-read data alone to determine the gene amplification mechanism. Thus, we mapped the serial short-read data to assembled consensus genomes of the index isolates. We observed progressive increase in mapping depth for the serial isolates of patient 4 (strains MB1860-2573) up to 27-fold for bla OXA-1 from the initial to final isolate (Fig. 3B ). The increase in mapping depth did not extend to the nearby bla CTX-M-15 gene but rather was confined to the MB1860TU region that contained aac-(6')-Ib-cr, bla OXA-1 , ΔcatB3, aac(3')-IIa, and tmrB ( Fig. 3B ). Patient 10 (strains MB2315-2446-2649) had increased mapping depth of bla CTX-M-55 of ~2X fold for isolate B (MB2446) and ~7X fold for isolate C (MB2649). This isolate carried an ISEcp1-bla CTX-M-55 -IS26 4.5 kbp TU, which appeared through the short-read data to be the element that was being amplified and will be discussed in detail below. Patient 11 serial isolates, EC215 (isolate A) and MB2489 (isolate B), both had the presence of two copies of bla OXA-1 and bla , one on a chromosome and one on a plasmid as previously mentioned. Nevertheless, no further increased mapping was detected between the original and serial isolate. We confirmed that the gene mapping depth observed by sequencing correlated with gene levels as measured by qRT-PCR (Fig. S3) .
In order to determine whether the increases in gene mapping depth was associated with augmented transcript levels of the β -lactamase encoding genes, we isolated RNA, converted to cDNA, and then performed TaqMan qRT-PCR for bla OXA and bla CTX-M relative to the endogenous control gene rpsL. We observed in patient 4 isolates a statistically significant increase in bla OXA-1, but not bla CTX-M transcript levels in the serial isolates as compared to the index isolate that was consistent with read mapping depth data (Fig. 4A) . The bla CTX-M transcript levels were only measured in patient 10 since bla OXA-1 was not present in these strains. We observed a significant increase in bla CTX-M transcript levels for the second encoding genes in conjunction with IS6 elements, which corresponds with our short-read mapping depth results indicating gene amplification (Fig. 5B ). For strain MB2374 (isolate B), there were multiple reads that had 2X or greater copies of MB1860TU including one 31.5 kb ONT read which captured three contiguous repeats. We could determine through an alignment of the MB2374 long-reads with our reference chromosome MB1860 using an in-house developed tool called SVAnts in conjunction with a short-read pileup analysis that this 10X TU amplification only occurred at the original MB1860TU locus.
As well as having TU amplification at the original MB1860TU site, additional gene amplification in the non-CP-CRE strains MB2463 (isolate C) and MB2649 (isolate D) resulted from the translocation and insertion of MB1860TU into the aforementioned flanking regions (Fig. 5B) . Remarkably, the ompC disruption found in the short-read data analysis (Fig. 2) for the non-CP-CRE strains MB2463 (isolate C) and MB2649 (isolate D) resulted from the translocation and insertion of MB1860TU within the ompC gene (Fig. 5B ). This ompC gene disruption was confirmed through the identification of multiple longreads that covered the full insertion (>30 kbp) site as well as identifying partial assemblies of this insertion on individual contigs. We found two individual long reads that were able to span the full length of the MB1860TU array (3X copies) which disrupts ompC for isolate MB2463 (isolate C) and confirmed 2 0 the exact MB1860TU insertion location within ompC (c.504_505ins). We could not identify individual long reads that spanned the entire ompC insertion site in MB2649 (isolate D); however, the same genetic context that confirmed translocation and interruption of ompC was detected in individual long reads at the 5' and 3' regions of the ompC insertion site respectively. Additionally, a second MB1860TU translocation and insertion downstream of the original MB1860TU locus occurred in strain MB2649
(isolate D) within a hypothetical protein which resides between flanking genes thiD encoding a kinase and the HTH-type transcriptional repressor gene yvoA (Fig. 5B ). This progressive amplification was consistent with our qRT-PCR data (Fig. S3A, Fig. 4A ).
The serial isolates from patient 10 (MB2315, MB2446, and MB2649) contain a different TU and gene amplification mechanism compared to patient 4 isolates (Fig. 6 ). MB2315 (isolate A) harbors bla located between ISEcp1 and an IS26 element, designated as MB2315TU, on a 141 kbp IncF conjugative plasmid. There are three additional small plasmids present in MB2315, one of which is a high copy number (~6X) 6.8 kbp plasmid that had 100% coverage, 100% BLAST ID with an E. coli plasmid identified as p7 from an unpublished collection in the UK (GenBank Accession #: CP023375). The p7 plasmid contains a small sul2-Δaph(3")-Ib-dfrA14-Δaph(3")-Ib-aph(6')-Id resistance island. MB2446
(isolate B) also carries MB2315TU on a similar IncF plasmid compared to the index strain. Additionally, in MB2446 the IncF plasmid-encoded MB2315TU translocates and inserts within the p7 plasmid in between dfrA14 and Δaph(3")-Ib to generate three copies of MB2315TU , thereby creating a 19 kbp plasmid that reverts to a low copy (1X) number plasmid. In MB2649 (isolate C) bla CTX-M-55 is on the same IncF plasmid as MB2446 (100%cov;99.99%ID) as well as the p7 plasmid; however, there is just a single ISEcp1-bla CTX-M-55 element on the p7 plasmid that has dropped IS26 from the full length MB2315TU.
Interestingly, the MB2649 p7 plasmid reverts back to a high (6X) copy number plasmid with 1X copies of bla suggesting that this configuration of the MB2315TU is more stable within this p7 plasmid.
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Both isolates of patient 11 (EC215 and MB2489) had two copies of bla and bla OXA-1 on the MB1860TU-like structures located on the chromosome (Fig. S2A ) and an IncFIB conjugative plasmid respectively (Fig. S2B) , as previously described in the index isolate section. Consistent with our previous qRT-PCR (Fig.S3C, Fig. 4C ), there was no indication in the ONT data of additional gene amplification via the MB1860TU occurring in this set of serial isolates.
The copyright holder for this preprint . http://dx.doi.org/10.1101/616961 doi: bioRxiv preprint first posted online Apr. 23, 2019; ompC-apbE-ada-yojI-mqo-eco-3 ' is ~65 kbp 5' to the region where the initial MB1860TU is located in MB1860. Furthermore, the 3' region is defined by 5'-thiD-hyp-yvoA-3' and located ~65 kbp from the initial MB1860TU region. In lieu of annotating the full region, these regions are omitted and indicated by blue dashes. (B) ONT sequencing assemblies and SVAnts long-read characterization of TU amplification All rights reserved. No reuse allowed without permission.
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Similar to strain MB1860, increased mapping depth was present in strain MB101 surrounding aac-(6')-Ib', bla OXA-1 , Δ catB3, aac(3')-IIc, and tmrB (~11-fold). We were able to identify a single ONT read that had 9X TUs containing the aforementioned AMR genes on the MB101 chromosome. The TU repeat structure from MB101 had 100% coverage; 99.9% ID with MB1860TU found in serial isolates from patients 4 and 11 (Fig. S5A ). We were unable to determine the genetic context of the 3' flanking end of the insertion due to the size of the TU and lack of an index reference genome resulting in an incomplete MB101 chromosome structure. The MB101 short-read analysis also indicated that there was higher coverage depth of bla . Similar to strain MB1860, in strain MB101 the key porin-encoding gene ompK36 was interrupted by a unique 5.4 kb TU that carries bla CTX-M-15 flanked by ISEcp1 and a truncated Tn2 transposase, designated as MB101TU (Fig. S4B ). MB101TU is also located on an IncFIB(K)_1_Kpn3 plasmid where it has inserted within a full length Tn2 transposon (Fig. S4C) . The presence of MB101TU on a plasmid inserted within a full-length Tn2 transposon, as well as the fact that a segment of the Tn2 transposon is found on the chromosomal insertion of ompK36, suggests a plasmid All rights reserved. No reuse allowed without permission.
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The mapping pattern for MB746A was quite similar to that of the serial isolates of patient 4 and patient 11 with increased mapping depth (~9X) of the bla OXA-1 IS6-mediated TU. However, this TU has also a tetracycline resistance operon and macrolide resistance operon inserted within a similar TU structure as MB1860TU (Fig. S5A) . Interestingly, we also saw a small IS26-aac(3)-IIa-tmrB-IS6 2X repeat (blue brackets on Fig. S5B ), which may indicate a similar replicative mechanism to how the full MB1860TU and MB1860TU-like structures replicate. Taken together, these findings indicate that the gene amplification and porin inactivation mechanisms detected in our serial isolates are also present in other non-CP-CRE strains.
Overexpression of bla OXA-1, but not bla CTX-M-15 , increases piperacillin-tazobactam minimum inhibitory concentration
Of the 28 strains in our cohort, 16 were piperacillin-tazobactam (TZP) resistant even though only a single isolate contained a gene encoding an enzyme predicted to hydrolyze TZP (bla ) . In light of the recent report of bla TEM-1 gene amplification leading to TZP resistance (23), we assessed the relationship between increased read mapping to β -lactamase encoding genes and TZP resistance. Indeed, nearly all strains with unexplained TZP resistance evidenced augmented depth of read mapping to β -lactamase encoding genes, typically for bla OXA-1 (Table 1) . Conversely, no TZP susceptible strain had such increased mapping depth. To directly evaluate the contribution of OXA-1 to β -lactam resistance, we cloned bla OXA-1 into an arabinose inducible expression system and assessed the effect of bla OXA-1 expression on ertapenem (ERT) and TZP resistance in the clean genetic background of DH5α E. coli, which is intrinsically sensitive to these antibiotics. Inducing bla OXA-1 expression increased TZP MIC 6.8-fold relative to uninduced cells ( Fig. 7B ) but did not alter the ERT MIC (Fig. 7A ). We observed a similar increase in TZP, but not ERT, MIC following overexpression of bla SHV-1 (Fig. 7B) . The lack of effect on All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint . http://dx.doi.org/10.1101/616961 doi: bioRxiv preprint first posted online Apr. 23, 2019;  ERT is consistent with a previous laboratory study in which β -lactamase encoding gene amplification only increased carbapenem MIC when porins were also inactivated (18). Given that both bla OXA-1 and bla CTX-M-15 were amplified in the TZP resistant strain MB101 (Table 1) , we sought to determine whether high level production of CTX-M-15 might contribute to TZP resistance. We observe no increase in ERT or TZP MIC following bla CTX-M-15 overexpression, although an increase in ceftriaxone MIC was observed consistent with the known activity of CTX-M-15 against this antibiotic ( Fig. 7C ) (33). Together with previous data (23), we conclude that overexpression of a variety of narrow spectrum β -lactamaseencoding genes can drive TZP resistance.
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Discussion
Enterobacteriaceae resistance to broad-spectrum β -lactams are among the most pressing AMR threats (34). There has been significant progress in elucidating the role of specific enzymes driving such resistance, such as carbapenemases and ESBLs (35). However, the underlying mechanisms of commonly observed non-CP-CRE as well as resistance to such widely used antibiotics as TZP remain poorly understood (8, 30) . Therefore, we used serial clinical isolates to resolve their genomes using both shortand long-read technologies which in turn facilitated demonstration that non-CP-CRE emerges from
ESBL-E through a combination of IS mediated β -lactamase TU translocation, subsequent β -lactamase gene amplification, and porin inactivation within our cohort. Moreover, we discovered that increased copy number of the gene encoding the class D narrow spectrum β -lactamase OXA-1 was strongly associated with TZP resistance in clinical isolates and that augmented bla OXA-1 expression increased TZP MIC under laboratory conditions. Taken together, these data markedly extend understanding of the mechanisms of progressive β -lactam resistance amongst Enterobacteriaceae.
Among the key findings of this study was that development of carbapenem resistance from an ESBL-E background rarely occurred due to acquisition of new genetic material but was rather due to adaptive mechanisms including mutations in porin genes and AMR encoding gene amplification. The single instance of carbapenemase acquisition in our study was due to replacement of an ESBL-E isolate with a completely new strain (patient 7). Our clinical findings regarding the role of porin loss and β -lactamase gene amplification leading to development of CRE generally mirrors laboratory-based analyses with a few key differences (10-12, 18, 20, 36) . Laboratory studies that generated CRE strains through serial passaging have consistently found that OmpC and OmpF porin production is reduced in carbapenem resistant isolates, but mechanisms have generally involved alterations in the porin regulatory protein
OmpR or in OmpR binding sites (18, 20) . Similarly, a recent study of a single patient with recurrent E.
coli infection identified a single amino change in OmpR as leading to loss of OmpC and OmpF expression with development of ertapenem resistance (15). Conversely, we observed direct inactivation All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint . http://dx.doi.org/10.1101/616961 doi: bioRxiv preprint first posted online Apr. 23, 2019; 1 of OmpC and OmpF via TU translocation or via insertions/deletions that resulted in frame-shifts whereas no alterations in OmpR were identified in our cohort. Although there have been reports of a wide variety of insertion sequences interrupting porin genes (37, 38), we are not aware of previous identification of porin interruption due to the translocation of TUs carrying AMR determinants. Given the length of the TUs as well as the fact that they have the ability to amplify and create TU arrays once inserted into the porin encoding genes, it is unlikely that targeted PCR based strategies or commonly used short-read approaches alone would have been able to identify the full extent of the TUs observed in our study. Thus, performing long read sequencing on larger cohorts of porin inactivated Enterobacteriaceae should help reveal whether AMR-carrying TUs mediating the disruption of porin genes occur widely but have not been previously identified due to the long and repetitive nature of the involved DNA structures.
The finding that bla OXA-1 amplification was consistently associated with progressive development of β -lactam resistance was somewhat surprising given that this enzyme is typically considered a narrow spectrum β -lactamase, although investigations have been limited particularly in regards to the activity of OXA-1-harboring organisms conferring TZP resistance (39). Several studies have found that cloning of bla OXA-1 onto a plasmid in E. coli resulted in TZP MICs that were in the resistant range (40, 41), yet there also have been consistent findings that Enterobacteriaceae strains containing bla OXA-1 can have TZP MICs ranging from fully susceptible to highly resistant (30, 42, 43 (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint . http://dx.doi.org/10.1101/616961 doi: bioRxiv preprint first posted online Apr. 23, 2019;  147/149 bla OXA-1 containing E. coli strains (32, 42). Thus, augmented bla OXA-1 expression may be quite common in E. coli and perhaps other Enterobacteriaceae given our finding of a highly similar bla containing TU in a K. pneumoniae strain (MB101).
Augmented expression of β -lactamase encoding genes has long been recognized in Enterobacteriaceae (19, 45) , but the long reads afforded by ONT sequencing allowed for direct visualization of an IS26 mediated mechanism. A report of a K. pneumoniae outbreak in 2012 identified a 220 kbp plasmid named pUUH239.2 containing IS26 elements, bla CTX-M-15 , bla TEM-1 , and bla OXA-1 that had previously been isolated from ST131 E. coli (32). The authors reported a suspected gene "triplication" involving IS26 elements in pUUH239.2 based on high-density short read mapping but did not specify the location. Moreover, when a strain containing pUUH2392.2 was passaged in the presence of carbapenems, there were increased copy numbers of bla genes, particularly bla OXA-1 (18). Similarly, the identification of the extensive copresence of bla OXA-1 and aac-(6')-Ib' noted that these genes were commonly present in the vicinity of IS26 elements but that the repetitive nature of the region made assembly via short read data impossible (42). Recent studies have shed insight into the potential mechanisms by which IS26-mediated translocatable units could create resistance gene arrays through both RecA-independent replication and RecA-dependent conservative (i.e. homologous recombination) mechanisms (46-48). Based on these previous studies as well as our own serial isolate data from patient 4, we hypothesize that the initial incorporation of the IS26-mediated TU as well as other translocations into the flanking regions of the chromosome occurred via a RecA-independent replication mechanism; gene amplification then occurred via homologous recombination. The high rates of IS26 elements in association with various bla genes (46) means that a diverse array of Enterobacteriaceae strains may have the capacity to develop progressive β -lactam resistance independently of the acquisition of exogenous β -lactamase encoding elements.
The copyright holder for this preprint . http://dx.doi.org/10.1101/616961 doi: bioRxiv preprint first posted online Apr. 23, 2019;  Nevertheless, it is important to note that IS26 mediated amplification of a TU was not the only mechanism of Enterobacteriaceae gene amplification present in our cohort. In patient 10, a complex series of events occurred which eventually resulted in ISEcp1 in association with bla CTX-M-55 being present on a high copy number plasmid (Fig. 6 ). This mechanism of gene amplification is similar to that in a recent study examining development of carbapenem resistance in association with increased copy number of an IncI plasmid encoding CMY-2 in an E. coli strain due to a mutation in the inc gene that controls plasmid copy number (20) . Similarly, MB1860TU containing bla OXA-1 as well as bla were present on both the chromosome and an IncF plasmid in patient 11 possibly indicating a mechanism by which this TU could be transferred intercellularly.
Despite the varied mechanisms present in our cohort, the bla gene amplification events could be readily identified using short-read data (Table 1) indicating the potential importance of incorporating read mapping depth into WGS based genotype-AMR phenotype relationships (30). Moreover, these findings provide a mechanism by which widely clinically used PCR based methodologies of assessing AMR, which cannot identify gene amplification events, may incorrectly predict strain AMR phenotypes (49).
In conclusion, we have used a combination of serial clinical isolates subjected to complementary WGS approaches to identify that a combination of porin inactivation and IS-mediated amplification of β -lactamase encoding genes underlies the emergence of non-CP-CRE from ESBL in Enterobacteriaceae.
We predict that more widespread application of long-read sequencing technologies will facilitate appreciation of the mechanisms and impact of TU-mediated translocations, porin disruptions, and gene amplifications on a diverse array of AMR pathogens.
Materials and Methods

Stain identification and clinical data analysis
We performed a retrospective cohort review of patients with ESBL-E bacteremia between January 2015
and July 2016 at The University of Texas MD Anderson Cancer Center in Houston, Texas. All patients with one or more episodes of ESBL-E bacteremia and who were 18 years old or greater were eligible for inclusion. Clinical and demographic characteristics were manually extracted from the electronic medical record and recorded using REDCap software (Vanderbilt University, Nashville, TN) (50). A waiver of informed consent to collect clinical data and analyze the isolates was provided by the MDACC IRB (PA15-0799). Antibiotic susceptibility testing was performed per routine clinical laboratory practice using an automated system (Vitek2 [bioMérieux, Marcy L'Étoile, France]) with additional testing performed as needed using individual antibiotic gradient strips (Etest [bioMérieux] ). ESBL production was assessed per routine laboratory practice on E. coli, K. pneumonia, and K. oxytoca isolates that were resistant to one or more oxyimino-cephalosporins (e.g. cefotaxime, ceftriaxone, or ceftazidime) using either the ESBL Etest (bioMérieux) or the Rapid ESBL Screen kit (Rosco, Taastrup, Denmark). Carbapenemase production was evaluated in the clinical lab on any Enterobacteriaceae isolate resistant to one more of the carbapenems using the Neo-Rapid CARB kit (Rosco) according to manufacturer's instructions. Recurrent bacteremia was defined as identification of organism of the same species in blood culture at any point during the follow-up period following at least one negative blood culture and completion of an antibiotic treatment regimen. Carbapenem resistance (CR) was defined as resistance to either ertapenem or meropenem using CLSI criteria (51).
Two additional strains, MB746A and MB101, are the sole carbapenem resistant, carbapenemase negative E. coli and K. pneumoniae strains respectively, present in a previously published study examining the role of whole genome sequencing (WGS) in predicting β -lactam resistance (30).
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Genome assembly was performed using SPAdes v3.9.1 (53). Depth of short read mapping to individual AMR encoding genes was quantitated relative to the average read mapping depth for the single-copy ribosome protein encoding genes rplM, rplN, rpsM, rpsS, and rpsH.
In order to determine clonality of isolates, we used a phylogenetic analysis approach along with in silico MLST. The pan-genome pipeline tool Roary-v3.12.0 was used to perform a core genome alignment of the SPAdes assembled genomes using the probabilistic alignment program PRANK (54, 55) . A core genome SNP matrix was generated with this data using an in-house custom Python script, which was subsequently used to build a maximum likelihood (ML) phylogenetic tree using RAxML-v8.2.12 (56). Multi-locus sequencing typing (MLST) was performed in silico using mlst-v2.15.1 (Seemann, T mlst Github:
https://github.com/tseemann/mlst; (57)) followed by the analysis of nested population structures within the ML phylogenetic tree using hierBAPS-v1.0.1 (58, 59).
Oxford Nanopore Technology (ONT) sequencing analysis
Serial, clonal isolates that demonstrated progressive β -lactam resistance as well as end-stage strains MB746A and MB10 that had previously undergone Illumina sequencing (30), underwent Oxford Nanopore Technology (ONT) sequencing. Library preps were completed using the SQK-RBK004 rapid barcoding kit and run on ONT MinION R9.4.1 flow cells using the ONT GridION X5 (Oxford, UK).
The 23, 2019; ONT fast5 data was generated using ONT MinKNOW software (2.2 v18.08.2) with subsequent basecalling using albacore-2.3.1. De novo assemblies were performed using . Assemblies underwent one round of short-read polishing using the HiSeq Illumina data with Racon-v.1.3.1 (61). The assembled, polished contigs were then manually inspected along with their de novo assembly graphs using the dotplot software package Gepard-v1.40 (62) and Bandage-v0.8.1(63) respectively. The python script simple-circularise.py (Kitson, E Simple-Circularise Github: https://github.com/Kzra/SimpleCircularise) was used to close complete circular structures, while Prokka-v1.13.3 (64) was used to find the dnaA gene for standardization of the chromosomal three prime start region. Plasmids were standardized, when possible with replication initiator protein genes identified with abricate-v0.8.10
(Seemann, T abricate Github: https://github.com/tseemann/abricate) using the PlasmidFinder database (updated 2018/11/24) (65). Contigs were then concatenated back into a multi-fasta file and underwent one round of long-read polishing with Nanopolish-v0.11.0 (Simpson, J nanopolish Github:
https://github.com/jts/nanopolish) followed by multiple rounds of racon polishing (61). The number of rounds of Racon polishing necessary were determined by mapping short-reads back onto the de novo assemblies and looking for the reduction of erroneous SNP calls using Snippy-v4.3.6 (Seemann, T snippy Github: https://github.com/tseemann/snippy). Once SNP calls were reduced to zero or plateaued to a minimum, we deemed this a consensus assembly. In particular cases where the assemblies were highly fragmented using solely Canu, these contigs were used as scaffolds along with both the short and long reads to create a hybrid assembly using the Unicycler-v0.4.7 wrapper with theexisting_long_read_assembly parameter (66). Final polished assemblies in both instances were then reannotated using Prokka-v1.13.3 (64) wherein they underwent further analysis described in the following sections [41] .
Identification of AMR elements and genetic variance among serial isolates
Presence of AMR elements was assessed using the Illumina HiSeq data using a previously published AMR detection pipeline (30). Variation in genetic content between the serial isolates was determined by
mapping short-read Illumina HiSeq data to the closed genome of the original isolate using Geneiousv11.0. All detected variations were confirmed via manual inspection of the mapping data as well as inspection of the complete de novo genome assemblies generated via ONT sequencing.
Identification of AMR determinants and mobile genetic elements (MGEs) of interest located on the longread data were parsed out using a multifaceted process. In cases where assemblies were not completely resolved due to putative large repeat regions that could not be fully captured on ONT long reads, we used a newly developed tool SVAnts-v0.1 (Hanson, B SVAnts Github:https://github.com/EpiBlake/SVAnts) to investigate subsets of ONT long reads. Briefly, this tool enabled us to find translocatable units (TUs) of interest captured fully or partially on individual reads as well as identify the regions in which the TU was inserted within a well assembled and annotated reference genome.
β -lactamase encoding gene and gene transcript level analysis
For both DNA and RNA quantitative reverse transcription PCR (qRT-PCR), indicated strains were grown in triplicate on two separate days (six biologic replicates) to mid-exponential phase (OD 600 ~ 0.5) in
Luria-Bertani (LB) broth (ThermoFisher) at 37º C shaking at 220 rpm. DNA isolation was performed using the DNEasy kit (Qiagen) and qRT-PCR was performed using TaqMan reagents on the StepOne
The
Plus Real Time PCR. The DNA levels of bla OXA-1 and bla CTX-M were determined relative to the rpsL control gene using the Δ Ct method (18).
For RNA analysis, cells were mixed 1:2 with RNAProtect (Qiagen) and harvested via centrifugation.
RNA was isolated from cell pellets using the RNEasy kit (Qiagen) and converted to cDNA using the High Capacity cDNA Reverse Transcription kKit (Applied Biosystems). Relative transcript levels of the β -lactamase encoding genes (bla OXA-1 and bla CTX-M ) were assayed using TaqMan reagents on the StepOne Plus Real Time PCR machine (Applied Biosystems). The transcript level of bla OXA-1 and bla CTX-M were determined relative to the endogenous control gene rpsL (68) using the Δ Ct method. QRT-PCR Primers and Probes are provided in Table S2 .
β -lactamase cloning and expression
The open reading frames of β-lactamases were amplified from genomic DNA of the K. pneumoniae strain MB101 using Q5 polymerase and the primers listed in Table S2 . Cloned ORFs were inserted into the arabinose inducible vector pBAD33 by Gibson assembly (69) of purified products. pBAD33bla and pBAD33bla OXA-1 were transformed into DH5α E. coli and were maintained with 50μg/mL chloramphenicol in cation adjusted Mueller Hinton (MHII) media. Minimum inhibitor concentration (MIC) assays were performed with ceftriaxone (Sandoz GmbH), ertapenem (Merck), or piperacillintazobactam (Fresenius Kabi USA) as follows. DH5α strains carrying pBAD33bla CTX-M-15 , pBAD33bla OXA-1 , or control vector were grown for 18 hours at 220 rpm at 37 o C in MHII with 50μg/mL chloramphenicol.
These cultures were diluted to approximately 5x10 5 CFU/mL in MHII with 0.2% L-Arabinose or vehicle control, without chloramphenicol. Each strain was exposed to serial dilutions of the above drugs in microtiter plates sealed with gas-permeable membranes (Midsci). Microtiter plates were incubated for 18
hours at 220rpm at 37 o C, followed by OD 600 measurement in a Biotek Synergy HT plate reader. The lowest tested antibiotic concentration yielding OD 600 measurement of 0.06 or less in at least two of three replicate wells was considered to be the MIC.
Statistical analyses
Bivariate comparisons between patients with recurrent bacteremia and patients with a single bacteremia episode were made with the Wilcoxon Rank-sum test and Fisher's exact test as appropriate based on covariate distributions. Comparisons of DNA and RNA levels among strains was performed using the Kruskall-Wallis test (when more than two strains were analyzed) or the Wilcoxon Rank-sum test (when two strains were analyzed). MIC comparisons were performed using ANOVA with Dunnett's test of multiple comparisons. Statistical significance was assigned as a two-sided P value < 0.05.
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